Market Overview

UPDATE: Cantor Fitzgerald Initiates Coverage on Bruker

Share:
Related BRKR
Benzinga's Top Downgrades
Cowen Downgrades Bruker To Market Perform

According to a research report published Thursday, Cantor Fitzgerald has initiated Bruker (NASDAQ: BRKR) with a Buy rating and $16 PT.

In the report, Cantor Fitzgerald said, "Bruker has a highly diversified high-end scientific instrumentation portfolio targeting life science, applied, and industrial markets. In our view, the company is well positioned to capitalize on high-growth market segments over the next several years and deliver above-market top line growth, leveraging internal R&D and strategic tuckins. Additionally, with below sector average margins, Bruker has significant upside for margin expansion in the medium-term."

Bruker closed Wednesday at $13.39.

Latest Ratings for BRKR

DateFirmActionFromTo
Apr 2015Leerink SwannUpgradesMarket PerformOutperform
Mar 2015UBSInitiates Coverage onNeutral
Feb 2015CitigroupMaintainsNeutral

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Initiation Analyst Ratings

 

Related Articles (BRKR)

Around the Web, We're Loving...

Get Benzinga's Newsletters